Prescription Patterns for Patients With Obsessive-Compulsive Disorder in Psychiatry Clinics in Addis Ababa: A Retrospective Multicenter Study.
| dc.contributor.advisor | Dr Mahlet Yared | |
| dc.contributor.advisor | Dr Wubalem Fekadu | |
| dc.contributor.author | Eyerusalem Atnafu | |
| dc.date.accessioned | 2026-11-13T13:11:35Z | |
| dc.date.available | 2026-11-13T13:11:35Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Background: Treatment guidelines for OCD recommend selective serotonin reuptake inhibitors (SSRIs) as first-line agents and Clomipramine as a second-line option. Several studies and the APA guideline indicate that higher doses of SSRIs are needed for adequate treatment of OCD compared to doses used in conditions like depression. Despite the evidence for high-dose SSRIs, surveys have shown that very few patients often receive evidence-based treatment. Objectives: To describe the prescription pattern and identify factors that influence the pattern. Methods: A retrospective chart review was conducted on 213 cases seen from January 1,2021 up to December 31,2025, in three public and two private institutions. Age, duration since diagnosis, academic background of prescribers and study settings were independent variables, while prescription pattern was the dependent variable. SPSS version 29 was used. Descriptive analysis and ANOVA were done. Results: Nine out of ten (90.8%) of the patients were treated with medications. SSRIs were prescribed as first-line for 77.7% and Clomipramine for 13.9%. Fluoxetine was the most prescribed first-line SSRI (66.7%) followed by sertraline (32.7%). Sertraline and Clomipramine were prescribed first-line by senior psychiatrists in 75.5% and 70.4% of cases respectively, while fluoxetine was prescribed first-line by residents in 52%. Two of the five study settings accounted for 85.9% of the first-line clomipramine prescriptions. The maximum prescribed doses of fluoxetine and sertraline were in range of low to medium doses for 68.3% and 83.4% respectively. In cases where medications were changed, the change occurred in ≤12 weeks for 47% on fluoxetine and 50% on sertraline. Objective clinical scales were used in 13.1%. Medication side effects were reported by 32.1% and 23.8% had a history of medication discontinuation. Psychotherapy was done for 40.4% of the patients. Several clinical variables were undocumented. Conclusion and Recommendation: The prescribed first-line medications generally align with established guidelines. However, the maximum doses of SSRIs are predominantly within the low to medium range for most patients. It is important to consider factors such as symptom severity when determining dosage. To enhance treatment outcomes, comprehensive documentation, the use of objective clinical scales, and staying current with treatment guidelines are strongly recommended. | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/9592 | |
| dc.language.iso | en | |
| dc.publisher | Addis Ababa Uinverstiy | |
| dc.subject | Obsessive compulsive disorder | |
| dc.subject | prescription pattern | |
| dc.subject | selective serotonin reuptake inhibitors | |
| dc.subject | clomipramine. | |
| dc.title | Prescription Patterns for Patients With Obsessive-Compulsive Disorder in Psychiatry Clinics in Addis Ababa: A Retrospective Multicenter Study. | |
| dc.type | Thesis |